We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$504M
AUM Growth
+$14.7M
Cap. Flow
-$5.5M
Cap. Flow %
-1.09%
Top 10 Hldgs %
55.23%
Holding
341
New
21
Increased
27
Reduced
60
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
176
Northrop Grumman
NOC
$80.3B
$25K 0.01%
54
UL icon
177
Unilever
UL
$137B
$25K 0.01%
427
BLK icon
178
Blackrock
BLK
$174B
$24K ﹤0.01%
35
GSK icon
179
GSK
GSK
$104B
$24K ﹤0.01%
685
AMP icon
180
Ameriprise Financial
AMP
$49.2B
$23K ﹤0.01%
69
BURL icon
181
Burlington
BURL
$23.3B
$23K ﹤0.01%
143
NEA icon
182
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$23K ﹤0.01%
2,078
AZN icon
183
AstraZeneca
AZN
$249B
$22K ﹤0.01%
157
MRK icon
184
Merck
MRK
$317B
$22K ﹤0.01%
192
-2,386
-93% -$271K
SLCA
185
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$22K ﹤0.01%
1,800
MNST icon
186
Monster Beverage
MNST
$91.4B
$21K ﹤0.01%
360
WMT icon
187
Walmart Inc
WMT
$888B
$20K ﹤0.01%
378
+21
+6% +$1.06K
CME icon
188
CME Group
CME
$94.9B
$19K ﹤0.01%
100
VGT icon
189
Vanguard Information Technology ETF
VGT
$147B
$19K ﹤0.01%
336
CTSH icon
190
Cognizant
CTSH
$25.5B
$18K ﹤0.01%
270
MHD icon
191
BlackRock MuniHoldings Fund
MHD
$602M
$18K ﹤0.01%
1,554
AEP icon
192
American Electric Power
AEP
$67.9B
$17K ﹤0.01%
200
GILD icon
193
Gilead Sciences
GILD
$161B
$17K ﹤0.01%
218
HDB icon
194
HDFC Bank
HDB
$122B
$17K ﹤0.01%
496
PCTY icon
195
Paylocity
PCTY
$8.29B
$16K ﹤0.01%
89
WD icon
196
Walker & Dunlop
WD
$1.48B
$16K ﹤0.01%
199
DFS
197
DELISTED
Discover Financial Services
DFS
$15K ﹤0.01%
129
NFJ
198
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$15K ﹤0.01%
1,213
PSX icon
199
Phillips 66
PSX
$81.9B
$15K ﹤0.01%
162
+52
+47% +$5.05K
STXS icon
200
Stereotaxis
STXS
$136M
$15K ﹤0.01%
+10,000
New +$18.5K

Similar funds

Roble Belko & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Roble Belko & Company held 341 positions worth $504M, up 3% from $489M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Roble Belko & Company's Q2 2023 filing shows 21 new, 27 increased, 60 reduced and 20 closed positions. Its largest new stake was O-I Glass: 10,000 shares worth $213K. The largest sale was Vanguard International Dividend Appreciation ETF, an estimated $14.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.9% a quarter earlier, followed by Real Estate and Technology.

  • Roble Belko & Company's largest Q2 2023 buy was O-I Glass: 10,000 shares worth $213K.
  • Roble Belko & Company added most to Vanguard International High Dividend Yield ETF in Q2 2023, an estimated $12.9M increase.
  • Roble Belko & Company's biggest Q2 2023 reduction was Vanguard International Dividend Appreciation ETF, cutting an estimated $14.3M.
  • Roble Belko & Company fully exited iShares MSCI All Country Asia ex Japan ETF in Q2 2023, selling an estimated $1.11M.
  • Roble Belko & Company's ten largest holdings make up 55% of its $504M portfolio in Q2 2023.
  • Roble Belko & Company opened 21 new positions and closed 20 in Q2 2023.
  • Roble Belko & Company's portfolio value rose 3% quarter-over-quarter to $504M.

Based on Roble Belko & Company's 13F filing for Q2 2023, filed 4 Aug 2023.